Insider Trading activities at Bridgebio Oncology Therapeutics, Inc. (BBOT)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Bridgebio Oncology Therapeutics, Inc. (BBOT) since 2024 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Bridgebio Oncology Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1869105.

Total stock buying since 2024: $24,000,000.
Total stock sales since 2024: $0.
Total stock option exercises since 2024: $0.


4 insiders reported insider trading activities at Bridgebio Oncology Therapeutics, Inc. (BBOT):
Insider trading activities of Mckenna Mark C.
Insider trading activities of Chen Bihua
Insider trading activities of Holman Albert A Iii
Insider trading activities of Schmid John P.

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Bridgebio Oncology Therapeutics, Inc. (BBOT).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 0 $0 0 $0 4,262,126 $0
2024 2,400,000 $24,000,000 0 $0 0 $0

Table 2. Monthly summary of insider trading at Bridgebio Oncology Therapeutics, Inc. (BBOT).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2025-08 0 $0 0 $0 4,262,126 $0
2024-02 2,400,000 $24,000,000 0 $0 0 $0

Table 3. Detailed insider trading at Bridgebio Oncology Therapeutics, Inc. (BBOT)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2025-08-11 Holman Albert A Iii Option Ex 30,000 .00 0
2025-08-11 Mckenna Mark C. Option Ex 30,000 .00 0
2025-08-11 Chen Bihua Option Ex 4,172,126 .00 0
2025-08-11 Schmid John P. Option Ex 30,000 .00 0
2024-02-13 Chen Bihua (CEO and Chairperson) Buy 2,400,000 10.00 24,000,000

Insider trading activities including stock purchases, stock sales, and option exercises of BBOT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Bridgebio Oncology Therapeutics, Inc. (symbol BBOT, CIK number 1869105) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.